NSPX unknown pharma stock, only 9.5M O/S! Recent merger, cancer treatment patent, multiple research collaborations with university hospitals. Company looking up uplist to the NASDAQ Super super thin.....just nothing on the ask and BLOODY! Perfect bottom bounce setup http://globenewswire.com/news-release/2017/10/04/1140677/0/en/Inspyr-Therapeutics-Announces-Research-Collaboration-with-NYU-Winthrop-Hospital.html NSPX Due Diligence report